In all these in vitro infection models, a robust activation of HIF-1 was detectable via HIF-1α immunoblotting (Fig. 2, 3) and congruent results were obtained via immunohistochemistry using Hela-229 cells grown on coverslips (Fig. S1, not all data shown). The gene discussed is SETD2; the disease is infection.